Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.
- DOI
- 10.1182/blood.2024027038
- Published
- 2025 Jun 5
- Container
- Blood
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/blood.2024027038,
title = {Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.},
author = {Byrne C and Ward S and O'Sullivan J and Chion A and Lopes P and Baci B and Dowd C and Jordan D and Baker R and Preston RJS and Monopoli M and Turecek PL and Kotsias M and Cheeseman J and Moran AB and Gardner RA and Spencer DIR and Atiq F and O'Donnell JS},
year = {2025},
journal = {Blood},
doi = {10.1182/blood.2024027038},
url = {https://doi.org/10.1182/blood.2024027038}
}RIS
TY - JOUR TI - Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF. AU - Byrne C AU - Ward S AU - O'Sullivan J AU - Chion A AU - Lopes P AU - Baci B AU - Dowd C AU - Jordan D AU - Baker R AU - Preston RJS AU - Monopoli M AU - Turecek PL AU - Kotsias M AU - Cheeseman J AU - Moran AB AU - Gardner RA AU - Spencer DIR AU - Atiq F AU - O'Donnell JS PY - 2025 JO - Blood DO - 10.1182/blood.2024027038 UR - https://doi.org/10.1182/blood.2024027038 ER -
APA
C, B., S, W., J, O., A, C., P, L., B, B., C, D., D, J., R, B., RJS, P., M, M., PL, T., M, K., J, C., AB, M., RA, G., DIR, S., F, A., & JS, O. (2025). Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.. Blood. https://doi.org/10.1182/blood.2024027038
Source records
- pubmed · retrieved 2026-09-26T03:30:25.449Z